A Game-Changer for Diabetes: Polymer Delivers Insulin Painlessly Through Skin
November 25, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
PMS-Flurazepam [DSC]
Synonyms :
Class :
Hypnotics; Benzodiazepines
Brand Name :
PMS-Flurazepam [DSC]
Synonyms :
Class :
Hypnotics; Benzodiazepines
Dosage forms & Strengths:Â
Adult:Â
Schedule IV Capsule:Â
15 mgÂ
30 mgÂ
15 - 30
mg
Capsule
Orally 
at bedtime
may enhance the risk of CNS depression when combined with each other
The interaction may increase the risk of sedation, respiratory depression, and coma
may increase the CNS depressant effect
may increase the CNS depressant effect
may have an increased CNS depressive effect when combined with CNS depressants
CNS depressants may have an increased CNS depressive effect when combined with flunitrazepam
may have an increased CNS depressant effect when combined with dexmedetomidine
may have an increased CNS depressant effect when combined with CNS depressants
may increase the CNS depressant effect of CNS depressants
hydroxyzine: they may increase the CNS depressant effect of CNS Depressants
lemborexant: they may increase the CNS depressant effect of CNS Depressants
nalmefene: they may decrease the therapeutic effect of Opioid Agonists
may increase the CNS depressant effect of CNS Depressants
may increase the CNS depressant effect of Buprenorphine
oxolamine: they may increase the CNS depressant effect of CNS Depressants
amisulpride: they may increase the CNS depressant effect of CNS Depressants
ramosetron: they may increase the CNS depressant effect of CNS Depressants
linezolid: they may increase the CNS depressant effect of CNS Depressants
secretin: they may increase the CNS depressant effect of CNS Depressants
abciximab: it may decrease the excretion rate of abacavir CNS depressant
benoxaprofen: it may increase the risk of CNS depression
alpelisib: it may increase the risk of CNS depression
alogliptin: it may increase the risk of CNS depression
alosetron: it may increase the risk of CNS depression
albendazole: it may increase the risk of CNS depression
agomelatin: it may increase the risk of CNS depression
acyclovir: it may increase the risk of CNS depression
benzphetamine: it may increase the risk of CNS depression
benzydamine: it may increase the risk of CNS depression
cannabidiol: it may increase the risk of CNS depression
capsaicin: it may increase the risk of CNS depression
captopril: it may increase the risk of CNS depression
carbinoxamine: it may increase the risk of CNS depression
It may diminish the effect when combined with phenobarbital by affecting the intestinal/hepatic enzyme CYP3A4
azelastine may enhance the CNS depressant effect of CNS Depressants
azelastine/fluticasone intranasalÂ
may increase the CNS depressant effect
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
it increases the effect of CNS depressants
CNS depressants increase the effect of orphenadrine
it increases the effect of CNS depressants
CNS depressants increase the effect of paraldehyde
it increases the effect of CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with flunarizine
levosalbutamol: they may increase the CNS depressant effect of CNS Depressants
furosemide: it may increase the CNS depressant effect of CNS Depressants
aclidinium: they may increase the CNS depressant effect of CNS Depressants
mequitazine: they may increase the CNS depressant effect of CNS Depressants
cimetropium: they may increase the CNS depressant effect of CNS Depressants
potassium citrate: they may increase the CNS depressant effect of CNS Depressants
pitolisant: they may increase the CNS depressant effect of CNS Depressants
may increase the harmful effects of CNS depressants
may increase the harmful effects of CNS depressants
may increase the harmful effects of CNS depressants
may increase the harmful effects of CNS depressants
may increase the harmful effects of CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the CNS depressant effect of Opioid Agonists
may enhance the CNS depressant effect of Opioid Agonists
may enhance the CNS depressant effect of Opioid Agonists
may enhance the CNS depressant effect of Opioid Agonists
It may enhance sedation when combined with a shepherd's purse
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may have an increased effect of CNS depressant when combined with cannabinoid products
may have an increased effect of CNS depressant when combined with cannabinoid products
The potential for increased CNS depression risk or seriousness occurs when flurazepam is used together with pipecuronium
they decrease the effect of each other by pharmacodynamic antagonism
they decrease the effect of each other by pharmacodynamic antagonism
they decrease the effect of each other by pharmacodynamic antagonism
they decrease the effect of each other by pharmacodynamic antagonism
they decrease the effect of each other by pharmacodynamic antagonism
When flurazepam is used together with medazepam, the risk or seriousness of CNS depression is enhanced
The potential for CNS depression may enhanced when flurazepam is used together with fencamfamin
When flurazepam is used together with niaprazine, the risk or seriousness of CNS depression is enhanced
When flurazepam is used together with levosulpiride, the risk or seriousness of CNS depression is enhanced
may enhance the risk of CNS depression when combined with each other
may have an increased Effect of CNS depressant when combined with alcohol
the effect of flurazepam is decreased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism
CNS Depressants may enhance the CNS depressant effect of zolpidem
lisuride may enhance the CNS depressant effect of CNS Depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may have an increased CNS depressant effect when combined with brexanolone
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
it increases the effect of CNS depressants
CNS depressants increase the efficacy of cannabinoid-containing products
CNS depressants increase the efficacy of cannabinoid-containing products
it increases the effect of CNS depressants
it increases the effect of CNS depressants
may increase the toxic effect of CNS depressants
lofexidine: they may increase the CNS depressant effect of CNS Depressants
pramipexole: they may increase the sedative effect of CNS Depressants
may have an increased Effect of a CNS depressant when combined with methotrimeprazine
The sedative effect of metyrosine might be intensified by CNS depressants
chloroprocaine: they may increase the CNS depressant effect of CNS Depressants
ixabepilone: they may increase the CNS depressant effect of CNS Depressants
benzyl alcohol: they may increase the CNS depressant effect of CNS Depressants
bromopride: they may increase the CNS depressant effect of CNS Depressants
dimethindene: they may increase the CNS depressant effect of CNS Depressants
kava: they may increase the CNS depressant effect of CNS Depressants
flecainide: they may increase the CNS depressant effect of CNS Depressants
tedizolid: they may increase the CNS depressant effect of CNS Depressants
alfuzosin: they may increase the CNS depressant effect of CNS Depressants
dexketoprofen: they may increase the CNS depressant effect of CNS Depressants
aprotinin: they may increase the CNS depressant effect of CNS Depressants
may increase the CNS depressant effect of CNS depressants
abacavir: it may decrease the excretion rate of abacavir CNS depressant
abatacept: it may decrease the excretion rate of abacavir CNS depressant
alvimopan: it may increase the risk or severity of CNS depression
carmustine: it may increase the risk or severity of CNS depression
carprofen: it may increase the risk or severity of CNS depression
carvedilol: it may increase the risk or severity of CNS depression
dalfampridine: it may increase the risk or severity of CNS depression
cariprazine: it may increase the risk or severity of CNS depression
cetirizine: it may increase the risk or severity of CNS depression
celiprolol: it may increase the risk or severity of CNS depression
ajmaline: it may increase the risk or severity of CNS depression
apomorphine: it may increase the risk or severity of CNS depression
arformoterol: it may decreased the serum concentration of CNS depressants
oxybuprocaine: it may increase the metabolism of CNS depressants
axitinib: it may increase the metabolism of CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
CNS depressants increase the effect of oxycodone
CNS depressants increase the effect of opioid agonists serotonergic opioids
CNS depressants increase the effect of opioid agonists serotonergic opioids
CNS depressants increase the effect of opioid agonists serotonergic opioids
CNS depressants increase the effect of opioid agonists serotonergic opioids
it increases the toxicity of muscle relaxants
Frequency undefined:Â
Drowsiness Â
Dizziness Â
Lethargy Â
Light-headedness  Â
AtaxiaÂ
MyalgiaÂ
Chest painÂ
GU complaintsÂ
IrritabilityÂ
Pregnancy consideration:Â Â
Category XÂ
Breastfeeding warnings:Â Â
The drug is excreted in breastmilk, hence breastfeeding should not be done during drug therapyÂ
Pregnancy category:Â
Â
Patient information leafletÂ
Generic Name:Â flurazepamÂ
Pronounced: flu-rah-zeh-pamÂ
Why do we use flurazepam?Â
Flurazepam treats insomnia.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
